Filing Flows › Bio Key International (BKYI) › Q2 2026 › vs Q1 2026
Bio Key International (BKYI) Q2 2026 vs Q1 2026 (quarter over quarter)
Bio Key International's revenue fell $226K (-11%) from $2.1M in Q1 2026 to $1.9M in Q2 2026. The biggest changes: License −$137K (-10%); Hardware −$72K (-13%); Service −$17K (-7%).
Bio Key International, Q2 2026: revenue $1.9M (+13% year over year), operating margin -27.6%, net loss $577K, operating cash flow −$846K. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| License | $1.2M | $1.4M | −$137K | -10% |
| Hardware | $460K | $531K | −$72K | -13% |
| Service | $231K | $248K | −$17K | -7% |
| Revenue | $1.9M | $2.1M | −$226K | -11% |
| Net loss | $577K | $205K | $372K | +181% |
| Costs & expenses | $2.5M | $2.4M | $146K | +6% |
| Operating costs | $2.4M | $2.3M | $146K | +6% |
| Interest & other, net | $47K | $47K | $123 | +0.3% |
| Cost of revenue | $246K | $376K | −$130K | -35% |
| Research & development | $640K | $617K | $24K | +4% |
| SG&A | $1.6M | $1.3M | $253K | +19% |
| Operating cash sources | $963K | $470K | $493K | +105% |
| Depreciation & amortization | $74K | $71K | $3K | +5% |
| Share-based compensation | $43K | $41K | $2K | +5% |
| Cash used in operations | $846K | $358K | $488K | +136% |
| Net loss absorbed | $577K | $205K | $372K | +181% |
| Working capital & other | $386K | $264K | $121K | +46% |
Questions
How much did Bio Key International's revenue grow quarter over quarter in Q2 2026?
Bio Key International's revenue fell $226K (-11%) from $2.1M in Q1 2026 to $1.9M in Q2 2026.
What drove Bio Key International's revenue change in Q2 2026?
License −$137K (-10%); Hardware −$72K (-13%); Service −$17K (-7%).